Ranmali Bopitiya - Dec 1, 2024 Form 4 Insider Report for Oscar Health, Inc. (OSCR)

Role
EVP & Chief Legal Officer
Signature
/s/ Melissa Curtin, Attorney-in-fact
Stock symbol
OSCR
Transactions as of
Dec 1, 2024
Transactions value $
-$346,308
Form type
4
Date filed
12/3/2024, 04:16 PM
Previous filing
Sep 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OSCR Class A Common Stock Options Exercise +20.4K +9.33% 239K Dec 1, 2024 Direct F1
transaction OSCR Class A Common Stock Options Exercise +16.4K +6.87% 256K Dec 1, 2024 Direct F1
transaction OSCR Class A Common Stock Options Exercise +4.87K +1.9% 261K Dec 1, 2024 Direct F1
transaction OSCR Class A Common Stock Sale -$340K -18.8K -7.22% $18.07 242K Dec 2, 2024 Direct F2, F3
transaction OSCR Class A Common Stock Sale -$6.38K -345 -0.14% $18.48 241K Dec 2, 2024 Direct F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OSCR Restricted Stock Units Options Exercise $0 -20.4K -16.67% $0.00 102K Dec 1, 2024 Class A Common Stock 20.4K Direct F1, F5
transaction OSCR Restricted Stock Units Options Exercise $0 -16.4K -10% $0.00 148K Dec 1, 2024 Class A Common Stock 16.4K Direct F1, F6
transaction OSCR Restricted Stock Units Options Exercise $0 -4.87K -10% $0.00 43.8K Dec 1, 2024 Class A Common Stock 4.87K Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2 The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.46 to $18.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.46 to $18.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
F5 The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2022.
F6 The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2023.
F7 The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024.